75 related articles for article (PubMed ID: 21334421)
1. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
Gu YT; Xue YX; Wei XY; Zhang H; Li Y
Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
5. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
6. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
[TBL] [Abstract][Full Text] [Related]
7. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
Wang ZH; Xue YX; Liu YH
Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Zhang H; Xue YX
Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
Zhang Z; Xue Y; Liu Y; Shang X
Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
[TBL] [Abstract][Full Text] [Related]
11. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
Duan M; Xing Y; Guo J; Chen H; Zhang R
Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
[TBL] [Abstract][Full Text] [Related]
12. NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/FoxO1 signaling pathway in brain tumor microvascular endothelial cells.
Cai RP; Xue YX; Huang J; Wang JH; Wang JH; Zhao SY; Guan TT; Zhang Z; Gu YT
J Neurol Sci; 2016 Oct; 369():109-118. PubMed ID: 27653874
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
16. Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
Gu YT; Xue YX; Zhang H; Li Y; Liang XY
Cell Mol Neurobiol; 2011 May; 31(4):629-34. PubMed ID: 21331626
[TBL] [Abstract][Full Text] [Related]
17. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
18. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
Nag S; Venugopalan R; Stewart DJ
Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model.
Gu YT; Qin LJ; Qin X; Xu F
Neurosci Lett; 2009 Mar; 452(2):114-8. PubMed ID: 19135131
[TBL] [Abstract][Full Text] [Related]
20. Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood-tumor barrier.
Wang JE; Liu YH; Liu LB; Xia CY; Zhang Z; Xue YX
J Neurooncol; 2011 Apr; 102(2):213-24. PubMed ID: 20683758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
